JVMTX
Price
$26.63
Change
+$0.09 (+0.34%)
Updated
May 9 closing price
Net Assets
20.83B
TCMVX
Price
$16.11
Change
+$0.02 (+0.12%)
Updated
May 9 closing price
Net Assets
1.65B
Ad is loading...

JVMTX vs TCMVX

Header iconJVMTX vs TCMVX Comparison
Open Charts JVMTX vs TCMVXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$26.63
Change+$0.09 (+0.34%)
VolumeN/A
Net Assets20.83B
Nuveen Mid Cap Value A
Price$16.11
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets1.65B
JVMTX vs TCMVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVMTX vs. TCMVX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and TCMVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 20.8B vs. TCMVX (1.65B). TCMVX pays higher dividends than JVMTX: TCMVX (1.50) vs JVMTX (0.71). JVMTX was incepted earlier than TCMVX: JVMTX (12 years) vs TCMVX (23 years). JVMTX (1.11) is less costly to investors than TCMVX (0.81). TCMVX (48.00) and JVMTX (47.00) have comparable annual turnover. JVMTX has a lower initial minimum investment than TCMVX: JVMTX (0) vs TCMVX (2500). TCMVX annual gain was more profitable for investors over the last year : -3.92 vs. JVMTX (-8.11). JVMTX return over 5 years is better than : 53.69 vs. TCMVX (34.35).
JVMTXTCMVXJVMTX / TCMVX
Total Expense Ratio1.000.81123%
Annual Report Gross Expense Ratio1.110.81137%
Fund Existence12 years23 years-
Gain YTD-1.375-3.99834%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets20.8B1.65B1,261%
Annual Yield % from dividends0.711.5047%
Returns for 1 year-8.11-3.92207%
Returns for 3 years6.431.17548%
Returns for 5 years53.6934.35156%
Returns for 10 years31.78-28.74-111%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOOO35.610.25
+0.71%
BRP
OKE82.300.05
+0.06%
Oneok
TRAK21.94-0.03
-0.14%
ReposiTrak
SRCE61.04-0.45
-0.73%
1st Source Corp
BRNS0.87-0.03
-3.67%
Barinthus Biotherapeutics plc